Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Smith

Showing results (261-270 of 270) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 270 results.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
The contribution of <i>RBM20</i> truncating variants to human cardiomyopathyBrendan J Floyd, Joyce N Njoroge, Vikki A Krysov, et al.
Science Translational Medicine|June 26, 2020
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapyJanelle C Waite, Bei Wang, Lauric Haber, et al.
JAMA Cardiology|April 8, 2026
RBM20 Truncating Variants and Human CardiomyopathyBrendan J Floyd, Joyce N Njoroge, Vikki A Krysov, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Plasma cell identity escape drives resistance to anti-BCMA T-cell-redirecting therapy in multiple myelomaFrancesco Maura, Ciara L Freeman, Kylee H Maclachlan, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trialStephen Macfarlane, Timo Grimmer, Ken Teo, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Diagnostic Criteria and Disease Staging for Desmoplakin CardiomyopathyEric Smith, Alessio Gasperetti, Richard T Carrick, et al.
Heart Rhythm|April 29, 2026
External validation of the DSP-Risk Score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy associated genetic variantsAlessio Gasperetti, Barbara Bauce, Alexandros Protonotarios, et al.
Circulation|August 20, 2025
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin VariantsAlessio Gasperetti, Steven A Muller, Giovanni Peretto, et al.
Journal of Alzheimer'S Disease : JAD|December 5, 2024
Impact of a national dementia research consortium: The Canadian Consortium on Neurodegeneration in Aging (CCNA)Howard Chertkow, Natalie Phillips, Kenneth Rockwood, et al.
Neurology|December 19, 2022
Stroke Risk and Antithrombotic Treatment During Follow-up of Patients With Ischemic Stroke and Cortical Superficial SiderosisJoan Martí-Fàbregas, Pol Camps-Renom, Jonathan G Best, et al.
Pageof 27

Showing results (261-270 of 270) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 270 results.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
The contribution of <i>RBM20</i> truncating variants to human cardiomyopathyBrendan J Floyd, Joyce N Njoroge, Vikki A Krysov, et al.
Science Translational Medicine|June 26, 2020
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapyJanelle C Waite, Bei Wang, Lauric Haber, et al.
JAMA Cardiology|April 8, 2026
RBM20 Truncating Variants and Human CardiomyopathyBrendan J Floyd, Joyce N Njoroge, Vikki A Krysov, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Plasma cell identity escape drives resistance to anti-BCMA T-cell-redirecting therapy in multiple myelomaFrancesco Maura, Ciara L Freeman, Kylee H Maclachlan, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trialStephen Macfarlane, Timo Grimmer, Ken Teo, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Diagnostic Criteria and Disease Staging for Desmoplakin CardiomyopathyEric Smith, Alessio Gasperetti, Richard T Carrick, et al.
Heart Rhythm|April 29, 2026
External validation of the DSP-Risk Score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy associated genetic variantsAlessio Gasperetti, Barbara Bauce, Alexandros Protonotarios, et al.
Circulation|August 20, 2025
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin VariantsAlessio Gasperetti, Steven A Muller, Giovanni Peretto, et al.
Journal of Alzheimer'S Disease : JAD|December 5, 2024
Impact of a national dementia research consortium: The Canadian Consortium on Neurodegeneration in Aging (CCNA)Howard Chertkow, Natalie Phillips, Kenneth Rockwood, et al.
Neurology|December 19, 2022
Stroke Risk and Antithrombotic Treatment During Follow-up of Patients With Ischemic Stroke and Cortical Superficial SiderosisJoan Martí-Fàbregas, Pol Camps-Renom, Jonathan G Best, et al.
Pageof 27